Randomized, double‐blind, placebo‐controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA‐RESPONSE‐AHF)

Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial

(2019) David Fitchett et al.   CIRCULATION

Reduced hospitalization for heart failure using anti-diabetic drug dapagliflozin: implications of DECLARE–TIMI 58 for the basic science community

(2019) Hidekazu Kondo et al.   CARDIOVASCULAR RESEARCH

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

(2019) Vlado Perkovic et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Dapagliflozin And Prevention of Adverse‐outcomes in Heart Failure (DAPA‐HF) trial: baseline characteristics

(2019) John J.V. McMurray et al.   EUROPEAN JOURNAL OF HEART FAILURE

Evaluation of the effect of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR‐Reduced trial

(2019) Milton Packer et al.   EUROPEAN JOURNAL OF HEART FAILURE

Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial

(2019) Michael E. Nassif et al.   CIRCULATION

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

(2019) John J.V. McMurray et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of Serelaxin in Patients with Acute Heart Failure

(2019) Marco Metra et al.   NEW ENGLAND JOURNAL OF MEDICINE

Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)

(2018) Karin Rådholm et al.   CIRCULATION

SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review

(2018) Subodh Verma et al.   DIABETOLOGIA

Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure

(2018) Jorge Rubio-Gracia et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

SGLT2 inhibitors

(2018) Erika Opingari et al.   CURRENT OPINION IN CARDIOLOGY

Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME® trial

(2017) David Fitchett et al.   EUROPEAN HEART JOURNAL

Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure

(2017) Milton Packer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

(2017) Bruce Neal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME®trial

(2016) David Fitchett et al.   EUROPEAN HEART JOURNAL

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2016) Piotr Ponikowski et al.   EUROPEAN JOURNAL OF HEART FAILURE

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

(2015) Bernard Zinman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Terminology and definition of changes renal function in heart failure

(2014) K. Damman et al.   EUROPEAN HEART JOURNAL

Diuretic response in acute heart failure: clinical characteristics and prognostic significance

(2014) M. A. E. Valente et al.   EUROPEAN HEART JOURNAL

Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes

(2013) H. J. Lambers Heerspink et al.   DIABETES OBESITY & METABOLISM

The Chronic Kidney Disease Epidemiology Collaboration equation outperforms the Modification of Diet in Renal Disease equation for estimating glomerular filtration rate in chronic systolic heart failure

(2013) Mattia A.E. Valente et al.   EUROPEAN JOURNAL OF HEART FAILURE

Timing of Hemoconcentration During Treatment of Acute Decompensated Heart Failure and Subsequent Survival

(2013) Jeffrey M. Testani et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Diuretic Strategies in Patients with Acute Decompensated Heart Failure

(2011) G. Michael Felker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rolofylline, an Adenosine A1−Receptor Antagonist, in Acute Heart Failure

(2010) Barry M. Massie et al.   NEW ENGLAND JOURNAL OF MEDICINE